Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease

• Type of Material: Article
• Authors: Edward Morgan, Emory University; Cene Skubic, University of Ljubljana; Choon Lee, Emory University; Kaja B Cokan, University of Ljubljana; Damjana Rozman, University of Ljubljana
• Language: English
• Date: 2020-09-05
• Publisher: TAYLOR & FRANCIS LTD
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: Rights managed by Taylor & Francis
• License: Creative Commons Attribution-NonCommercial 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1080/03602532.2020.1817061
• Title of Journal or Parent Work: DRUG METABOLISM REVIEWS
• Volume: 52
• Issue: 4
• Start Page: 455
• End Page: 471
• Grant/Funding Information: This work was supported by the National Institutes of Health Institute of General Medical Science under Grant R01 GM 069971; the Slovenian Research Agency (ARRS) program under Grant P1-0390 and Project J1-9176; Kaja Blagotinsek Cokan was supported by a graduate fellowship of ARRS.
• Keywords: nitric oxide; enzyme inhibition; NF-KAPPA-B; Cytochrome P450; P450-MEDIATED DRUG-METABOLISM; 3A4 MESSENGER-RNA; HEPATOCYTE NUCLEAR FACTOR-4; Science & Technology; PROSTACYCLIN SYNTHASE; S-NITROSYLATION; HEPATIC CYTOCHROME-P450; DOWN-REGULATION; Life Sciences & Biomedicine; Pharmacology & Pharmacy; protein degradation; gene transcription; inflammation; NECROSIS-FACTOR-ALPHA; LANOSTEROL 14-ALPHA-DEMETHYLASE CYP51

Abstract

Many hepatic cytochrome P450 enzymes and their associated drug metabolizing activities are down-regulated in disease states, and much of this has been associated with inflammatory cytokines and their signaling pathways. One such pathway is the induction of inducible nitric oxide synthase (NOS2) and generation of nitric oxide (NO) in many tissues and cells including the liver and hepatocytes. Experiments in the 1990s demonstrated that NO could bind to and inhibit P450 enzymes, and suggested that inhibition of NOS could attenuate, and NO generation could mimic, the down-regulation by inflammatory stimuli of not only P450 catalytic activities but also of mRNA expression and protein levels of certain P450 enzymes. This review will summarize and examine the evidence that NO functionally inhibits and down-regulates P450 enzymes in vivo and in vitro, with a particular focus on the mechanisms by which these effects are achieved.